These effects have also been observed elsewhere, and those surveys indicate that identifying CMV gB as a TGF-β/Smad signaling inhibitor may be beneficial in developing effective therapeutic strategies using anti-TGF-β agents to promote tumor suppression [18]. The gene discussed is TGFB1; the disease is neoplasm.